This four-day course covers issues in regulatory science for gene and cell-therapy medicinal products.
This course is aimed at those involved in the production, testing and registration of advanced therapy medicinal products (ATMPs).
Members of the Cell and Gene Therapy Catapult Clinical Operations and Regulatory teams will be delivering two sessions as part of the course:
Belinda Carlsen, Head of Clinical Development
16:00-17:00, Mon 1st July
Natalie Ward, Senior Regulatory Affairs Manager - CMC specialist
ATMP to market
12:00-13:00, Thurs 4th July